PRISYM ID TO ATTEND INFORMA’S PHARMACEUTICAL AND MEDICAL DEVICE LABELING SUMMIT
PRISYM ID to exhibit its label lifecycle management system at Informa Life Sciences’ Pharmaceutical Labeling Summit in Berlin.
PRISYM ID, the leading provider of labeling solutions for the medical device and life sciences industries, is exhibiting on Stand 6 at the Informa Pharmaceutical Labeling Conference. The event takes place between the 27th and 28th October 2015 at the Maritim ProArte Hotel Berlin, Germany.
The Informa Pharmaceutical and Medical Device Labeling Summit is a principal occasion for those interested in the future of labeling and expert feedback around the complexities and challenges facing the industry. This year’s event will focus on supporting pharmaceutical and medical device organizations when faced with labeling challenges such as readability, country specific labeling requirements and regulatory compliance.
PRISYM ID will be showcasing its powerful solution, PRISYM 360, which has been developed to meet the strictest compliance requirements including FDA & EU regulations. The solution helps pharmaceutical and medical device organizations streamline all aspects of production label prints across manufacturing lines, distribution centres and third party manufacturers.
The Summit will also feature expert speakers, exclusive workshops and networking dinners across the three days. Each will discuss the most prominent themes within the industry enabling delegates to gain a comprehensive understanding of labeling strategies and future developments.
PRISYM ID’s SVP of Global Sales, Warren Ward-Stacey comments: “The team at PRISYM ID are delighted to be exhibiting at the Informa Pharmaceutical Labeling Conference. Our aim is to inform and support pharmaceutical and medical device organizations and provide a solution to the complexities of labeling. You can find us on Stand 6 and we look forward to talking to you about your requirements.”
For further information about PRISYM ID and to arrange a meeting during the conference, please contact email@example.com